The KFF survey reports that more than half of the firms that cover GLP-1s for weight loss require use of these medications be accompanied by services from complementary providers (such as a dietitian, psychologist, case worker or therapist)
Clinical studies have shown that patients using Ozempic can experience a substantial reduction in body weight
This uncertainty underlies the precautionary recommendations to discontinue these medications before conception
Metabolic profiling by Seahorse assay suggested that melatonin treated ILC2s exhibited decreased rates of basal respiration ( Figure 5P ), decreased spare respiratory capacity ( Figure 5Q ), and both reduced active rates of glycolysis ( Figure 5R ) as well as reduced glycolytic capacity ( Figure 5S )
Insurance plans vary, but some employersponsored and commercial health plans do help cover certain GLP1 medications, such as Wegovy (semaglutide) and Zepbound (tirzepatide)
For patients interested in whether genetic context might inform their GLP-1 response, this represents a meaningful difference in the available clinical tools
